Xenon Pharmaceuticals

(NASDAQ) XENE

Current Price$53.26

Market Cap$5.26B

Since IPO (2014)+418%

5 Year+214%

1 Year+84%

1 Month-8%

Xenon Pharmaceuticals Financials at a Glance

Market Cap

$5.26B

Revenue (TTM)

$0.00

Net Income (TTM)

$383.17M

EPS (TTM)

$-4.70

P/E Ratio

-11.56

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$53.26

Volume

9,349

Open

$54.36

Price

$53.26

Volume

9,349

Open

$54.36

Previous Close

$54.39

Daily Range

$53.19 - $54.43

52-Week Range

$28.19 - $63.95

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$53.26

Volume

9,349

Open

$54.36

Previous Close

$54.39

Daily Range

$53.19 - $54.43

52-Week Range

$28.19 - $63.95

XENE News

What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing

Jonathan PoncianoMay 18, 2026

Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know

Jonathan PoncianoMar 27, 2026

This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough

Jonathan PoncianoMar 13, 2026

Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data

Jonathan PoncianoFeb 19, 2026

investment-advisor-pitching-stocks-to-buy-getty

Page 1

XENE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xenon Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

370

CEO

Ian C. Mortimer, MBA

Website

www.xenon-pharma.com

Headquarters

Burnaby, BC V5G 4W8, CA

XENE Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-38%

Return on Capital

-31%

Return on Assets

-28%

Earnings Yield

-8.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.26B

Shares Outstanding

96.67M

Volume

9.35K

Avg. Volume

1.40M

Financials (TTM)

Gross Profit

$4.96M

Operating Income

$373.07M

EBITDA

$342.35M

Operating Cash Flow

$279.12M

Capital Expenditure

$799.00K

Free Cash Flow

$279.92M

Cash & ST Invst.

$548.89M

Total Debt

$7.94M

Xenon Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$5.26B

N/A

Market Cap/Employee

$16.64M

N/A

Employees

316

N/A

Net Income

$102.30M

-57.3%

EBITDA

$111.74M

-55.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$1.09B

+101.0%

Accounts Receivable

$1.17M

-86.5%

Inventory

$0.00

N/A

Long Term Debt

$5.93M

-18.7%

Short Term Debt

$1.56M

+13.0%

Return on Assets

-27.63%

N/A

Return on Invested Capital

-30.64%

N/A

Free Cash Flow

$89.03M

-44.3%

Operating Cash Flow

$88.90M

-44.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LEGNLegend Biotech Corporation

LEGNLegend Biotech Corporation$27.13-1.52%

CGONCG Oncology, Inc. Common stock

CGONCG Oncology, Inc. Common stock$63.57-5.02%

APGEApogee Therapeutics, Inc.

APGEApogee Therapeutics, Inc.$78.97-2.67%

SRRKScholar Rock Holding Corporation

SRRKScholar Rock Holding Corporation$47.37-4.01%

CNTACentessa Pharmaceuticals plc

CNTACentessa Pharmaceuticals plc$39.59+0.01%

CELCCelcuity Inc.

CELCCelcuity Inc.$131.29-4.64%

TVTXTravere Therapeutics, Inc.

TVTXTravere Therapeutics, Inc.$42.86+0.62%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.95-0.07%

TET1 Energy Inc.

TET1 Energy Inc.$6.58+0.16%

AIIORobo.ai

AIIORobo.ai$5.91+0.47%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.26-0.00%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$700.50-0.01%

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF$5.21+0.18%

SNAPSnap

SNAPSnap$5.67+0.02%

Questions About XENE

What is the current price of Xenon Pharmaceuticals?

Xenon Pharmaceuticals is trading at $53.26 per share.

What is the 52-week range for Xenon Pharmaceuticals?

Over the past 52 weeks, Xenon Pharmaceuticals has traded between $28.19 and $63.95.

How much debt does Xenon Pharmaceuticals have?

As of the most recent reporting period, Xenon Pharmaceuticals reported total debt of $7.49M.

How much cash does Xenon Pharmaceuticals have on hand?

Xenon Pharmaceuticals reported $545.87M in cash and cash equivalents in its most recent financial results.

What is Xenon Pharmaceuticals’s dividend yield?

Xenon Pharmaceuticals does not currently have a dividend yield.

Xenon Pharmaceuticals

Xenon Pharmaceuticals Financials at a Glance

XENE News

What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing

Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know

This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough

Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data

3 Growth Stocks Near 52-Week Highs to Buy Anyway

Is Xenon Pharmaceuticals a Good Stock to Buy Now?

Why Xenon Pharmaceuticals Stock Is Screaming Higher Today

Is Now a Good Time To Buy Neurocrine Biosciences?

XENE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Xenon Pharmaceuticals

XENE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Xenon Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About XENE

What is the current price of Xenon Pharmaceuticals?

What is the 52-week range for Xenon Pharmaceuticals?

How much debt does Xenon Pharmaceuticals have?

How much cash does Xenon Pharmaceuticals have on hand?

What is Xenon Pharmaceuticals’s dividend yield?

Premium Investing Services